205 related articles for article (PubMed ID: 11408275)
1. Inflammatory bowel disease is associated with changes of enterocytic junctions.
Gassler N; Rohr C; Schneider A; Kartenbeck J; Bach A; Obermüller N; Otto HF; Autschbach F
Am J Physiol Gastrointest Liver Physiol; 2001 Jul; 281(1):G216-28. PubMed ID: 11408275
[TBL] [Abstract][Full Text] [Related]
2. The epithelium in inflammatory bowel disease: potential role of endocytosis of junctional proteins in barrier disruption.
Ivanov AI; Nusrat A; Parkos CA
Novartis Found Symp; 2004; 263():115-24; discussion 124-32, 211-8. PubMed ID: 15669638
[TBL] [Abstract][Full Text] [Related]
3. Inflammatory bowel disease and the apical junctional complex.
Bruewer M; Samarin S; Nusrat A
Ann N Y Acad Sci; 2006 Aug; 1072():242-52. PubMed ID: 17057204
[TBL] [Abstract][Full Text] [Related]
4. Neutrophil transmigration in inflammatory bowel disease is associated with differential expression of epithelial intercellular junction proteins.
Kucharzik T; Walsh SV; Chen J; Parkos CA; Nusrat A
Am J Pathol; 2001 Dec; 159(6):2001-9. PubMed ID: 11733350
[TBL] [Abstract][Full Text] [Related]
5. Expression of catenins and E-cadherin during epithelial restitution in inflammatory bowel disease.
Karayiannakis AJ; Syrigos KN; Efstathiou J; Valizadeh A; Noda M; Playford RJ; Kmiot W; Pignatelli M
J Pathol; 1998 Aug; 185(4):413-8. PubMed ID: 9828841
[TBL] [Abstract][Full Text] [Related]
6. Changes in expression and distribution of claudin 2, 5 and 8 lead to discontinuous tight junctions and barrier dysfunction in active Crohn's disease.
Zeissig S; Bürgel N; Günzel D; Richter J; Mankertz J; Wahnschaffe U; Kroesen AJ; Zeitz M; Fromm M; Schulzke JD
Gut; 2007 Jan; 56(1):61-72. PubMed ID: 16822808
[TBL] [Abstract][Full Text] [Related]
7. Unravelling the pathogenesis of inflammatory bowel disease.
Xavier RJ; Podolsky DK
Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
[TBL] [Abstract][Full Text] [Related]
8. PTPN2 Regulates Interactions Between Macrophages and Intestinal Epithelial Cells to Promote Intestinal Barrier Function.
Spalinger MR; Sayoc-Becerra A; Santos AN; Shawki A; Canale V; Krishnan M; Niechcial A; Obialo N; Scharl M; Li J; Nair MG; McCole DF
Gastroenterology; 2020 Nov; 159(5):1763-1777.e14. PubMed ID: 32652144
[TBL] [Abstract][Full Text] [Related]
9. Targeting desmosomal adhesion and signalling for intestinal barrier stabilization in inflammatory bowel diseases-Lessons from experimental models and patients.
Schlegel N; Boerner K; Waschke J
Acta Physiol (Oxf); 2021 Jan; 231(1):e13492. PubMed ID: 32419327
[TBL] [Abstract][Full Text] [Related]
10. Inflammation-induced Occludin Downregulation Limits Epithelial Apoptosis by Suppressing Caspase-3 Expression.
Kuo WT; Shen L; Zuo L; Shashikanth N; Ong MLDM; Wu L; Zha J; Edelblum KL; Wang Y; Wang Y; Nilsen SP; Turner JR
Gastroenterology; 2019 Nov; 157(5):1323-1337. PubMed ID: 31401143
[TBL] [Abstract][Full Text] [Related]
11. Short Chain Fatty Acids (SCFAs)-Mediated Gut Epithelial and Immune Regulation and Its Relevance for Inflammatory Bowel Diseases.
Parada Venegas D; De la Fuente MK; Landskron G; González MJ; Quera R; Dijkstra G; Harmsen HJM; Faber KN; Hermoso MA
Front Immunol; 2019; 10():277. PubMed ID: 30915065
[TBL] [Abstract][Full Text] [Related]
12. Cellular and Molecular Therapeutic Targets in Inflammatory Bowel Disease-Focusing on Intestinal Barrier Function.
Schoultz I; Keita ÅV
Cells; 2019 Feb; 8(2):. PubMed ID: 30813280
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Disease: Inflammatory Bowel Diseases.
Ramos GP; Papadakis KA
Mayo Clin Proc; 2019 Jan; 94(1):155-165. PubMed ID: 30611442
[TBL] [Abstract][Full Text] [Related]
14. Translating Immunology into Therapeutic Concepts for Inflammatory Bowel Disease.
Uhlig HH; Powrie F
Annu Rev Immunol; 2018 Apr; 36():755-781. PubMed ID: 29677472
[TBL] [Abstract][Full Text] [Related]
15. Gut microbiota in the pathogenesis of inflammatory bowel disease.
Nishida A; Inoue R; Inatomi O; Bamba S; Naito Y; Andoh A
Clin J Gastroenterol; 2018 Feb; 11(1):1-10. PubMed ID: 29285689
[TBL] [Abstract][Full Text] [Related]
16. Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches.
Sartor RB; Wu GD
Gastroenterology; 2017 Feb; 152(2):327-339.e4. PubMed ID: 27769810
[TBL] [Abstract][Full Text] [Related]
17. A decrease of the butyrate-producing species Roseburia hominis and Faecalibacterium prausnitzii defines dysbiosis in patients with ulcerative colitis.
Machiels K; Joossens M; Sabino J; De Preter V; Arijs I; Eeckhaut V; Ballet V; Claes K; Van Immerseel F; Verbeke K; Ferrante M; Verhaegen J; Rutgeerts P; Vermeire S
Gut; 2014 Aug; 63(8):1275-83. PubMed ID: 24021287
[TBL] [Abstract][Full Text] [Related]
18. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
[TBL] [Abstract][Full Text] [Related]
19. Epithelial tight junctions in intestinal inflammation.
Schulzke JD; Ploeger S; Amasheh M; Fromm A; Zeissig S; Troeger H; Richter J; Bojarski C; Schumann M; Fromm M
Ann N Y Acad Sci; 2009 May; 1165():294-300. PubMed ID: 19538319
[TBL] [Abstract][Full Text] [Related]
20. Genetic basis for increased intestinal permeability in families with Crohn's disease: role of CARD15 3020insC mutation?
Buhner S; Buning C; Genschel J; Kling K; Herrmann D; Dignass A; Kuechler I; Krueger S; Schmidt HH; Lochs H
Gut; 2006 Mar; 55(3):342-7. PubMed ID: 16000642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
